-
Invitation to join the new PANCREATIC CANCER Helix
We are pleased to invite you to join our new “PANCREATIC CANCER Helix" community. This Helix arises from the newly funded EIC Pathfinder Project “L...
Learn more...Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority. Neither the European Union nor the granting authority can be held responsible for them. This project has received funding from the European Union’s Horizon 2020 or Horizon Europe research and innovation programme under grant agreement No 101130740.
Funded by
the European Union -
Postdoctoral fellows for EIC Pathfinder project
We are looking to hire two postdocs at the In Silico Modelling Group (https://in-silico-modelling.ucy.ac.cy) of the Mechanical & Manufacturing Engi...
Learn more...Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority. Neither the European Union nor the granting authority can be held responsible for them. This project has received funding from the European Union’s Horizon 2020 or Horizon Europe research and innovation programme under grant agreement No 101129853.
Funded by
the European Union -
CUCrowdhelix User
Seeking international collaborations for TÜBİTAK – The Slovak Academy of Sciences (SAS) Bilateral Cooperation Call
Project Proposal
-
-
Chemotherapy Device for Imatinib Drug Monitoring
Background - The effectiveness of many anticancer drugs varies greatly from patient to patient, with risks of incorrect dosages and adverse side ef...
-
Anti-Cancer Efficient and Non-Toxic Palladium Compounds
Background - Platinum-based antineoplastic drugs have been used since the late 1970s, although they sometimes show significant nephro- and neurotox...
-
Bicyclic Peptide Inhibitors of the Human Urokinase-Type Plasminogen Activator (HUPA)
Background - Bicyclic peptides are small polypeptides that exhibit properties typical of both monoclonal antibodies (high target specificity and af...
-
Reversible Monoacylglycerol Lipase (MAGL) Inhibitors for Neurodegenerative Pathologies and Tumour Treatment
Background - The enzyme monoacylglycerol lipase (MAGL), which is part of the endocannabinoid system (ECS), has therapeutic potential for the treatm...
-
Less Toxic Chemotherapy with Palladium
Background - Targeted, efficient and non-toxic anti-cancer drugs: a new class of palladium compounds could be used as innovative chemotherapeutic m...
-
Copper Compounds for the Treatment of Ovarian Cancer
Background - The present invention is a nanomaterial containing a pharmaceutical composition based on copper (II) nitroprusside (CuNP) for use in...
